OncoRevive helps in early cancer care by using nanotechnology and advanced blood analysis.
OncoRevive has raised $119K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.
OncoRevive's investors include Antler, Techstars, Lift Women.
OncoRevive is headquartered in Brunswick, Australia.
OncoRevive helps in early cancer care by using nanotechnology and advanced blood analysis.
OncoRevive is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncoRevive — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/oncorevive. Accessed August 13, 2026.
VCBacked. (2025). OncoRevive — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/oncorevive
{{cite web |title=OncoRevive — Funding & Investors |url=https://www.vcbacked.co/company/oncorevive |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated